Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Take-Two Shares Tumble as GTA VI Release Gets Pushed Back

Dieter Jaworski by Dieter Jaworski
November 18, 2025
in Earnings, Gaming & Metaverse, Tech & Software
0
Take-Two Stock
0
SHARES
98
VIEWS
Share on FacebookShare on Twitter

Video game powerhouse Take-Two Interactive delivered exceptional quarterly results that were completely overshadowed by disappointing news about its most anticipated title. Despite posting financial figures that smashed expectations, the company’s stock faced significant selling pressure after announcing a six-month delay for Grand Theft Auto VI.

Investor Focus Shifts from Strong Results to Delayed Launch

The market’s reaction was swift and severe. Take-Two shares plummeted approximately 8% in after-hours trading following the GTA VI postponement announcement. The decline demonstrates that for investors, the timing of the next blockbuster release carries more weight than current financial performance, even when that performance is remarkably strong.

Rockstar Games, Take-Two’s development studio, explained the delay from May to November 2026 as necessary for final polishing. However, this scheduling change threatens to impact growth projections for fiscal year 2027, creating concern among shareholders who had been anticipating the title’s earlier arrival.

Quarterly Performance Exceeds All Targets

Take-Two’s second quarter for fiscal 2026 presented outstanding operational results. Revenue climbed 33% to reach $1.96 billion, substantially surpassing the company’s own guidance. Earnings per share also beat analyst forecasts by a wide margin, coming in at $1.46.

The company’s sports franchise demonstrated particular strength, with NBA 2K26 achieving record performance. Mobile gaming operations also contributed significantly with robust results across their portfolio. This powerful showing prompted management to raise its full-year outlook for the second consecutive time.

Should investors sell immediately? Or is it worth buying Take-Two?

Revised Annual Guidance Reflects Current Strength

Based on the quarter’s exceptional performance, Take-Two has upgraded its fiscal 2026 revenue projection to a range between $6.4 billion and $6.5 billion. This represents a substantial increase over previous estimates and indicates management’s confidence in the company’s ongoing business operations.

The guidance revision highlights the underlying health of Take-Two’s current game portfolio and suggests strong ongoing demand for existing titles, even without the immediate contribution of its most anticipated release.

Analyst Community Maintains Constructive Outlook

Despite the market’s negative reaction to the delay, financial analysts largely maintain positive positions on Take-Two’s prospects. BMO Capital Markets raised its price target to $275, suggesting the current weakness might represent a buying opportunity. UBS followed with an even more optimistic assessment, boosting its target to $292.

The average price target among covering analysts stands at $270, indicating substantial potential upside from current trading levels. The key question remaining for investors is whether the delay represents prudent quality assurance or signals deeper development challenges. The coming months will reveal whether Take-Two can restore investor confidence ahead of the new November 2026 release window.

Ad

Take-Two Stock: Buy or Sell?! New Take-Two Analysis from February 7 delivers the answer:

The latest Take-Two figures speak for themselves: Urgent action needed for Take-Two investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Take-Two: Buy or sell? Read more here...

Tags: Take-Two
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
elf Beauty Stock

e.l.f. Beauty Shares Plunge Following Disappointing Earnings Report

Pony AI Stock

Pony AI Shares Continue Their Steep Descent

Motorola Stock

Legal Storm Clouds Gather Over Motorola Shares

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com